The benefit of learning together with your friend is that you keep each other accountable and have meaningful discussions about what you're learning.
Courtlyn
Promotion and Events Specialist
Drive your healthcare organisation forward with innovative strategies
TBD
2 months, online
4-6 hours per week
Our participants tell us that taking this programme together with their colleagues helps to share common language and accelerate impact.
We hope you find the same. Special pricing is available for groups.
The benefit of learning together with your friend is that you keep each other accountable and have meaningful discussions about what you're learning.
Courtlyn
Promotion and Events SpecialistBased on the information you provided, your team is eligible for a special discount, for Healthcare Strategy starting on TBD .
We’ve sent you an email with enrolment next steps. If you’re ready to enrol now, click the button below.
Have questions? Email us at group-enrollments@emeritus.org.
Apply before 6 October 2022 and avail early bird tuition assistance of USD 150.
Use code NUSMED150TA while applying.
New features:
● 2 Live Sessions with Faculty
● Immersive real-world scenarios to better prepare participants for the challenging situation that impact healthcare organizations
WhatsApp an Advisor on +65 8014 3066
Have questions? Our Advisor will assist you promptly.
This programme is especially helpful for professionals aspiring to:
90+ Recorded Video Lectures
12 Assignments
12 Guest Speakers
8 Discussion Boards
5 Real-World Case Studies
2 Live Sessions with Faculty
1 Role-Play Simulation
The programme is 8 modules, each comprehensively covering the aspects of healthcare strategies in an organisation.
Creating a Nondisruptive Solution for China’s Healthcare System
Implementing the Biodesign Process for Medical Device Innovation in Head & Neck Surgery
Multidisciplinary Teamwork, Physician-Led Governance, and Patient-Centered Culture Drive World-Class Health Care
A New Model for Bangladesh
Medical-legal issues in obstetrics and gynaecology
Interactive role-play sessions with programme leader where participants will get an opportunity to immerse themselves in real-world scenarios and build first person experience to handle situations which are most challenging and bear high financial impact on healthcare organisations; while enhancing 'value' for patients, keeping customers at the heart of corporate decision making.
The demand for healthcare in Asia is fast-growing, driven by shifting demographics, consumer expectations and regulations. In response to these ongoing disruptions, digital ecosystems and technologies continue to emerge. These innovations enable healthcare professionals to reimagine the future of care delivery and management and what operational excellence looks like.
But the world's fastest-growing healthcare market is complex, which can make it challenging for professionals and organisations to stay ahead of the curve and ensure better treatment quality and outcomes across all touchpoints.
In the Healthcare Strategy Programme, offered by NUS Yong Loo Lin School of Medicine, you will:
Singapore's healthcare market is expected to grow to USD 49.4 Billion by 2029.
Asia’s healthcare market could more than double from 2017 to 2024, with a 12% average annual growth rate compared to 5% growth pace projected for the global healthcare market.
Healthcare Strategy is designed for mid- to senior-level healthcare professionals who aspire to gain a holistic view of Asia’s fast-growing healthcare market.
The programme is applicable across major industries, including Hospitals and Healthcare, Higher Education, IT and Services, Pharmaceuticals, Management Consulting, Medical Devices, Marketing and Advertising, Government Administration, International Trade and Development, and Customer Goods.
Dr Jeremy Lim Fung Yen
Dr Rena Dharmawan
Dr Prem Kumar Nair
Dr Jason CH Yap
Dr Joseph Mocanu
Dr T Thirumoorthy
Dr Jeremy Lim Fung Yen
MBBS, MRCS (Edin), MPH, MMed (Surg), FAMS Associate Professor, NUS Saw Swee Hock School of Public Health
Professor Jeremy is the co-founder and CEO of AMiLi, the first dedicated gut microbiome full-service company in Southeast Asia. He is also Director of the Leadership Institute for Global Health Transformation (LIGHT) at the NUS Saw Swee Hock School of Public Health where he works to enhance cooperation, capacity building and knowledge sharing across the region.
Trained in surgery and public health, Professor Jeremy attained various post graduate qualifications, including membership in the Royal College of Surgeons (Edinburgh), masters of medicine (NUS) and masters of public health (Johns Hopkins, as a Fulbright scholarship awardee). He was an inaugural fellow of the Asia Society A21 young leaders programme in 2006.
Dr Rena Dharmawan
MD, MMed (Surg), FRCS (Edin), BSc (Biomed Engineering) Assistant Professor, Duke-NUS Medical School
Dr Rena Dharmawan believes that with the right innovation, one can improve the lives of millions at a time. She is a Consultant at Division of Surgical Oncology in National Cancer Centre Singapore and Fellow in the SingHealth Duke-NUS Head and Neck Centre. Dr Rena Dharmawan also holds a joint appointment as an Assistant Professor and Entrepeneur-in-Residence at the Center of Technology and Development (CTeD) at Duke-NUS Medical School, Singapore.
In 2014, she was one of four nationally-selected fellows in the Singapore-Stanford Biodesign (SSB) Programme, a year-long fellowship that aims to train and nurture the next generation of medical technology innovators for Singapore and Asia. After the fellowship, Dr Rena Dharmawan co-founded 2 Singapore-based medtech startups: Privi Medical and Jaga-Me. Privi Medical is developing a safe, drug-free and comfortable solution to help millions of people suffering from early stage haemorrhoids manage their symptoms effectively in the comfort and privacy of their homes.
Dr Prem Kumar Nair
MBBS, MBA(Distinction) Adjunct Associate Professor, NUS Saw Swee Hock School of Public Health
Dr Prem Kumar Nair oversees the operations and management of IHH’s business units in Singapore, which includes Mount Elizabeth, Mount Elizabeth Novena, Gleneagles and Parkway East hospitals, primary healthcare network Parkway Shenton, as well as ancillary and education entities such as Parkway Radiology, Parkway Laboratory, Parkway Rehab, Parkway Cancer Centre and Parkway College.
As the Country CEO for Singapore, he also plays a decisive role in IHH Singapore’s strategic growth and outreach efforts in overseas markets, ensuring that Singapore remains an attractive and trusted option for patients in the region.
Dr Jason CH Yap
MBBS, MMed (Public Health), FAMS MBA (Information Systems), GDipCS Vice Dean (Practice); Director (Public Health Translation); Associate Professor, NUS Saw Swee Hock School of Public Health
Dr Jason CH Yap joins NUS from Singapore’s national enabling agency for Integrated Care, where he served as Chief Knowledge Officer and Senior Public Health Physician and continues as Senior Visiting Consultant and Associate Programme Director in the National Preventive Medicine Residency.
He is a public health physician with extensive experience of working across operations, business and information systems in public and private healthcare. His previous roles include leading Singapore Medicine (the marketing of Singapore’s medical travel services) and as an IT director in the National Healthcare Group, Singapore.
Dr Joseph Mocanu
PhD, MBA, BSc (Molecular Genetics & Molecular Biology) Guest Lecturer, NUS & Managing Director of Verge HealthTech Fund
Dr Joseph Mocanu is the Managing Direct of Verge HealthTech Fund focusing on early stage healthcare technology companies relevant to emerging markets. Prior to this, Dr Joseph was a scientist researching new cancer therapies, a medical device entrepreneur, and a management consultant for Oliver Wyman where he led life sciences and digital health across Asia.
He has 19 scientific publications, 3 patents, and has made investments in 24 healthcare technology companies to date. Dr Joseph has a PhD from the University of Toronto, and an MBA from the Richard Ivey School of Business.
Dr T Thirumoorthy
MBBS (Malaya), FRCP, FAMS (Dermatology), Masters in Healthcare Ethics & Law, Masters in Counselling Adjunct Professor & PDP Programme Director, Duke-NUS Medical School
Dr T Thirumoorthy graduated as a medical doctor from the University of Malaya in 1972 and went on to be trained in internal medicine and dermatology. He served in both public and private practice and returning in 2002 to be the founding director and senior consultant dermatologist of the dermatology department at the Singapore General Hospital.
Dr Thirumoorthy is the Founding Director of the Singapore Medical Association (SMA) Centre for Medical Ethics and Professionalism (SMA-CMEP) from 2000 to 2003. The SMA Council re-appointed Dr Thiru to helm the SMA CMEP as its Executive Director from 2011 to 2015. He has been on the lead Teaching Faculty of the Ministry of Health/SMA Course on Ethics & Professionalism for Advanced Specialist Trainees since 2004. In 2004, Dr Thirumoorthy was awarded the SMA Merit Award for services contributed in medical ethics and professionalism.
Distinguished Fellow, Asia Research Institute, National University of Singapore
Visiting Professor, Department of Medicine, National University of Singapore
Dean, NUS Yong Loo Lin School of Medicine, National University of Singapore
President and CEO Ayala Healthcare Holdings Inc
Founder, Chair, and CEO Praava Health
Founder and CEO ZaZaZu Pte Ltd
Group Chief Patient Officer National University Health System
Founder, CEO and Chairman Doctor Anywhere
Group CEO Icon Group
Deputy Chief Medical Officer Jiahui Health, China
Chief Executive Officer Mobio Interactive
Chief Executive Officer Esco Lifesciences
Upon successful completion of the Programme, participants will be awarded a verified digital certificate by NUS Yong Loo Lin School of Medicine.
Download BrochureAll certificate images are for illustrative purposes only and may be subject to change at the discretion of NUS Yong Loo Lin School of Medicine.
